ATE92960T1 - Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren. - Google Patents

Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren.

Info

Publication number
ATE92960T1
ATE92960T1 AT87401301T AT87401301T ATE92960T1 AT E92960 T1 ATE92960 T1 AT E92960T1 AT 87401301 T AT87401301 T AT 87401301T AT 87401301 T AT87401301 T AT 87401301T AT E92960 T1 ATE92960 T1 AT E92960T1
Authority
AT
Austria
Prior art keywords
alpha
particularly use
kallikrein inhibitors
antitrypsin variants
antitrypsin
Prior art date
Application number
AT87401301T
Other languages
English (en)
Inventor
Sophie Jallat
Michael Courtney
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE92960T1 publication Critical patent/ATE92960T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87401301T 1986-06-10 1987-06-10 Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren. ATE92960T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8608386A FR2599752B1 (fr) 1986-06-10 1986-06-10 Variants de l'alpha1- antitrypsine utiles notamment comme inhibiteurs de la kallikreine
EP87401301A EP0253690B1 (de) 1986-06-10 1987-06-10 Alpha-1-antitrypsin-Varianten, besonders verwendbar als Kallikrein-Inhibitoren

Publications (1)

Publication Number Publication Date
ATE92960T1 true ATE92960T1 (de) 1993-08-15

Family

ID=9336200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87401301T ATE92960T1 (de) 1986-06-10 1987-06-10 Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren.

Country Status (13)

Country Link
US (1) US4973668A (de)
EP (1) EP0253690B1 (de)
JP (1) JP2649804B2 (de)
KR (1) KR880000575A (de)
AT (1) ATE92960T1 (de)
AU (1) AU610500B2 (de)
CA (1) CA1328706C (de)
DE (1) DE3786961T2 (de)
DK (1) DK173131B1 (de)
FR (1) FR2599752B1 (de)
IE (1) IE61060B1 (de)
PT (1) PT85047B (de)
ZA (1) ZA874123B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0401508B1 (de) * 1989-05-13 1994-11-23 Bayer Ag Proteinaseninhibitoren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
WO1993018159A2 (en) 1992-03-09 1993-09-16 Chiron Corporation Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells
WO1995002055A1 (en) * 1993-07-09 1995-01-19 Michael Laskowski Novel protein inhibitors of serine proteinases (e.g. furin) derived from turkey ovomucoid third domain
WO1996010638A1 (en) * 1994-09-30 1996-04-11 Ppl Therapeutics (Scotland) Ltd. Alpha-1-antitrypsin and antithrombine-iii variants
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
US20110318359A1 (en) * 2008-12-02 2011-12-29 Feener Edward P Method for reducing blood pressure using inhibitors of plasma kallikrein
AU2012267546B2 (en) 2011-06-10 2015-12-24 Ionis Pharmaceuticals, Inc. Methods for modulating kallikrein (KLKB1) expression
CA2840614A1 (en) 2011-06-29 2013-01-03 Isis Pharmaceuticals, Inc. Methods for modulating kallikrein (klkb1) expression
EP3038627B1 (de) 2013-08-28 2020-03-04 Ionis Pharmaceuticals, Inc. Modulation der prekallikrein (pkk)-expression
GB201322091D0 (en) 2013-12-13 2014-01-29 Cambridge Entpr Ltd Modified serpins for the treatment of bleeding disorders
EP3137091B1 (de) 2014-05-01 2020-12-02 Ionis Pharmaceuticals, Inc. Konjugate von antisens-oligonukleotiden und deren verwendung zur modulation der pkk-expression
WO2018154044A1 (en) 2017-02-23 2018-08-30 Umc Utrecht Holding B.V. Modified serpins for the treatment of bradykinin-mediated disease
WO2018183705A1 (en) 2017-03-29 2018-10-04 Cornell University Oxidation-resistant aat gene therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984000560A1 (en) * 1982-08-04 1984-02-16 Nat Res Dev Molecular cloning of the gene for human anti-haemophilic factor ix
US4711848A (en) * 1984-03-14 1987-12-08 Zymogenetics, Inc. Site specific mutagenesis in alpha-1-antitrypsin
DE3585969D1 (de) * 1984-06-14 1992-06-11 Chiron Corp Protease-inhibitoren des alpha-1-antitrypsin typs mit modifizierter aktiever stelle und deren herstellung.
DE3581328D1 (de) * 1984-06-19 1991-02-21 Transgene Sa Derivate des menschlichen alpha-1-antitrypins und verfahren zu deren herstellung.
CA1299120C (en) * 1984-10-22 1992-04-21 Glenn Kawasaki Stable dna constructs for expression of alpha-1-antitrypsin
EP0195592B1 (de) * 1985-03-15 1992-04-22 Btg International Limited Faktor-IX-Protein
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
ATE74164T1 (de) * 1985-04-22 1992-04-15 Genetics Inst Herstellung mit hoher leistung des aktivfaktors ix.
FR2601033B1 (fr) * 1986-07-02 1990-01-19 Transgene Sa Variants de l'alpha-antitryspine humaine glycosylee et procede pour la preparation

Also Published As

Publication number Publication date
US4973668A (en) 1990-11-27
DE3786961D1 (de) 1993-09-16
IE871374L (en) 1987-12-10
KR880000575A (ko) 1988-03-26
AU610500B2 (en) 1991-05-23
EP0253690B1 (de) 1993-08-11
DK173131B1 (da) 2000-01-31
DK285087D0 (da) 1987-06-03
ZA874123B (en) 1987-12-09
CA1328706C (fr) 1994-04-19
JPS6379899A (ja) 1988-04-09
FR2599752A1 (fr) 1987-12-11
DK285087A (da) 1987-12-11
DE3786961T2 (de) 1994-01-20
FR2599752B1 (fr) 1989-11-03
PT85047B (pt) 1990-03-08
PT85047A (fr) 1987-07-01
JP2649804B2 (ja) 1997-09-03
AU7362587A (en) 1987-12-17
EP0253690A1 (de) 1988-01-20
IE61060B1 (en) 1994-09-21

Similar Documents

Publication Publication Date Title
ES2148140T3 (es) Inhibidores de la biosintesis del oxido nitrico.
DK0810209T3 (da) Alpha - and beta-aminosyre-hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
ES2173341T3 (es) Compuestos inhibidores de proteasa retroviral.
ATE92960T1 (de) Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren.
AP9200410A0 (en) Retroviral protease inhibitors.
DK0607334T3 (da) Cycliske urinstoffer og analoger anvendelige som retrovirale proteasehæmmere
YU20199A (sh) Heterociklični sukcinimidi i njihova primena kao metaloproteinaznih inhibitora
ES2088839T3 (es) Compuestos que inhiben las proteasas retrovirales.
MY136789A (en) Metalloproteinase inhibitors
NO983688L (no) Serin-protease-inhibitorer
ES2036562T3 (es) Un procedimiento para produccion de un derivado de pirrolidinamida.
ES2173477T3 (es) Derivados de tetrahidronaftaleno y su utilizacion terapeutica.
BR9810163B1 (pt) compostos liberadores de àxido nÍtricos.
FI935777A0 (fi) Inhibitorer foer HIV-proteas anvaendbara vid behandling av AIDS
NO951593D0 (no) Nye substituerte azetidinoner som antiinflammatoriske og antidegenerative midler
ES2052560T3 (es) Compuestos difluorcetonicos.
DE69728164D1 (de) Peptidomimetische inhibitoren von der protease des menschlichen cytomegalovirus
ES2051954T3 (es) 2-aminotiazoles substituidos.
FI951078A0 (fi) Retrovirusinfektion inhibitio
ATE279182T1 (de) Verwendung spezieller verbindungen zur prophylaxe und therapie von hepatitis c
ES2060711T3 (es) 2-aminotiazoles substituidos.
ECSP993018A (es) Nuevos inhibidores de proteasas, particularmente inhibidores de cisteina y serina proteasas
FI935707L (fi) Anvaendning av hirudinderivat som trombininhibitorer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee